000 | 01994 a2200529 4500 | ||
---|---|---|---|
005 | 20250516090724.0 | ||
264 | 0 | _c20121001 | |
008 | 201210s 0 0 eng d | ||
022 | _a1520-4804 | ||
024 | 7 |
_a10.1021/jm300256z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStaedler, Davide | |
245 | 0 | 0 |
_aCytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cJun 2012 |
||
300 |
_a4990-5002 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAlkynes _xchemical synthesis |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xchemical synthesis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnticholesteremic Agents _xchemical synthesis |
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 | _aAtorvastatin |
650 | 0 | 4 |
_aBrain _xblood supply |
650 | 0 | 4 |
_aCarbamates _xchemical synthesis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 |
_aCyclohexanes _xchemical synthesis |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEndothelial Cells _xcytology |
650 | 0 | 4 |
_aHeptanoic Acids _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aIntramolecular Transferases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMicrosomes, Liver _xenzymology |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xpathology |
650 | 0 | 4 |
_aPyrroles _xpharmacology |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aChapuis-Bernasconi, Catherine | |
700 | 1 | _aDehmlow, Henrietta | |
700 | 1 | _aFischer, Holger | |
700 | 1 | _aJuillerat-Jeanneret, Lucienne | |
700 | 1 | _aAebi, Johannes D | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 55 _gno. 11 _gp. 4990-5002 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm300256z _zAvailable from publisher's website |
999 |
_c21731357 _d21731357 |